Treatment of human contamination with plutonium and americium: Would orally administered Ca- or Zn-DTPA be effective?

Radiation Protection Dosimetry

Volumn 127, Issue 1-4, 2007, Pages 469-471

  Taylor, David M ^a   Hodgson, Susan A ^b   Stradling, Neil ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMERICIUM; AMERICIUM 241; PENTETATE CALCIUM; PENTETATE ZINC; PLUTONIUM; PLUTONIUM 238; CHELATING AGENT; PENTETIC ACID; RADIOPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENVIRONMENTAL RADIOACTIVITY; FEMALE; NONHUMAN; RADIATION ACCIDENT; RADIATION EXPOSURE; RADIATION INJURY; RADIOACTIVE CONTAMINATION; RAT; BIOASSAY; BIOLOGICAL MODEL; BODY BURDEN; COMPARATIVE STUDY; COMPUTER SIMULATION; HUMAN; METHODOLOGY; ORAL DRUG ADMINISTRATION; RADIATION DOSE; RADIOMETRY; RELATIVE BIOLOGIC EFFECTIVENESS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADMINISTRATION, ORAL; AMERICIUM; BIOLOGICAL ASSAY; BODY BURDEN; CHELATING AGENTS; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; PENTETIC ACID; PLUTONIUM; RADIATION DOSAGE; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RADIOMETRY; RELATIVE BIOLOGICAL EFFECTIVENESS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 49649089294     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/ncm299     Document Type: Article

References (10)

1. Food and Drug Administration (FDA) Guidance for industry on pentetate calcium trisodium and pentetate zinc trisodium for treatment of internal contamination with plutonium, americium or curium; availability. Federal Register 68(187), 53984-53988 (2002).
2. Stather, J. W., Stradling, G. N., Gray, S. A., Moody, J. C. and Hodgson, A. Use of DTPA for increasing the rate of elimination of plutonium-238 and americium-241 from rodents after their inhalation as the nitrates. Hum. Toxicol. 4, 573-582 (1985).
3. Stradling, G. N., Gray, S. A., Ellender, M., Pearce, M., Wilson, I., Moody, J. C. and Hodgson, A. Removal of inhaled plutonium and americium for the rat by administration of ZnDTPA in Drinking water. Hum. Exp. Toxicol. 12, 233-239 (1993).
4. Gray, S. A., Pearce, M. J., Stradling, G. N., Wilson, I., Hodgson, A. and Isaacs, K. R. Optimising the removal of inhaled plutonium and americium from the rat by administration of ZnDTPA in drinking water. Hum. Exp. Toxicol. 14, 902-908 (1995).
5. 239Pu in rats. Health Phys. 38, 147-158 (1980).
6. Breitenstein, B. D. and Palmer, H. E. Lifetime follow-up of the 1976 americium accident victim. Radiat. Prot.Dosim. 26, 317-322 (1989).
7. Taylor, D. M. and Volf, V. Oral treatment of plutonium incorporation Plzen Lek. Sborn. (Pilsen Medical Reports) (Suppl. 62), 101-102 (1990).
8. Lagerquist, C. R., Putzier, E. A. and Piltingsgrud, C. W. Bioassay and body counter results for the first two years following an acute plutonium exposure. Health Phys. 13, 965-972 (1967).
9. Henge-Napoli, M. H., Stradling, G. N. and Taylor, D. M. Decorporation of radionuclides from the human body. Radiat Prot Dosim. 87 (1), 5-57 (2000).
10. Miller, S. C., Liu, G., Bruenger, F. W. and Lloyd, R. D. Efficacy of orally administered amphipathic polyaminopolycarboxylic acid chelators for the removal of plutonium and americium: Comparison with injected Zn-DTPA in the rat. Radiat. Prot. Dosim. 118(4), 412-420 (2006).